Imatinib I Drugs and Medications
Imatinib I Drugs and Medications
Imatinib
Gleevec, a brand of imatinib mesylate, is used in the treatment of Chronic Myeloid Leukemia, a rare form of cancer.
Top: Health: Pharmacy: Drugs and Medications: I: Imatinib:
-
- Information on dosage, usage, side effects, interactions, and drug comparisons including generics when available.
-
- Imatinib mesylate. Features prescribing and reimbursement information for US residents.
-
- Press release about the STI571 trials in the UK.
-
- Features a history of the drug, interviews with medical professionals, message boards, FAQs, news, and an album of thank yous to Dr. Druker, Gleevec's primary researcher.
-
- Howard Hughes Medical Institute article, available in HTML and PDF format.
-
- Features information from the FDA's Center for Drug Evaluation and Research including news releases, FAQs, approval letter, and draft package insert.
-
- Discussion forum for anyone interested in Gleevec treatments.
-
- Patient FAQ in html format with a link to approved labeling in pdf format.
-
- Features newsletters from this group of patients who are taking part in the Gleevec trials to treat gastrointestinal stromal tumors, a form of cancer.
-
- Features articles, news releases, FAQs, and drug information.
-
- Manufacturer's information on this prescription medication used in the treatment of Chronic Myelogenous Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST).
-
- Prescribing and patient information, from the manufacturer.
-
- Reports, news releases, list of current drug trials, and articles from the NIH's National Cancer Institute.
-
- Information from the RxList.
|
